IDH1 and central nervous system cancer: Co-evaluation of histological grade and molecular markers demonstrated the prognostic association of grading in lower-grade gliomas irrespective of the status of IDH1/2, 1p/19q and TERTp. Notably, no single molecular marker, including IDH1/2 mutation, superseded histological grading in prognostication.